wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38404422-C984E91F-8D9B-44F9-B6BD-C6F6445F12D7
Q38404422-C984E91F-8D9B-44F9-B6BD-C6F6445F12D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-C984E91F-8D9B-44F9-B6BD-C6F6445F12D7
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
P2860
Q38404422-C984E91F-8D9B-44F9-B6BD-C6F6445F12D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-C984E91F-8D9B-44F9-B6BD-C6F6445F12D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38c4135fe57d9f81540a31d707b3606ba694db31
P2860
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION).